【摘要】：隨著經(jīng)濟(jì)全球化步伐的不斷邁進(jìn),中國(guó)醫(yī)藥行業(yè)的競(jìng)爭(zhēng)日趨白日化。國(guó)外大型醫(yī)藥企業(yè)憑借強(qiáng)大的經(jīng)濟(jì)實(shí)力和先進(jìn)的產(chǎn)品技術(shù),不斷占據(jù)中國(guó)高端醫(yī)藥市場(chǎng)；同時(shí)國(guó)內(nèi)私營(yíng)制藥企業(yè),依賴高效靈活的運(yùn)營(yíng)模式和管理機(jī)制,不斷利用價(jià)格戰(zhàn)搶占中低端普藥市場(chǎng)。面對(duì)如此激烈的競(jìng)爭(zhēng)形勢(shì),質(zhì)量和價(jià)格已經(jīng)成為企業(yè)市場(chǎng)成敗的關(guān)鍵要素。以豐田公司為代表的企業(yè)通過(guò)精益生產(chǎn)方式降低成本、提高質(zhì)量、快速靈活響應(yīng)市場(chǎng),取得巨大成功,為處于競(jìng)爭(zhēng)弱勢(shì)的國(guó)內(nèi)醫(yī)藥企業(yè)帶了新的希望。 在目前國(guó)內(nèi)醫(yī)藥市場(chǎng)仿制藥品種不斷增加,新醫(yī)改政策對(duì)藥品價(jià)格的持續(xù)施壓,國(guó)家藥監(jiān)機(jī)構(gòu)對(duì)藥品質(zhì)量審批要求的大幅提升,以及隨著人民幣不斷升值、勞動(dòng)力成本的不斷升高以及環(huán)太湖流域?qū)Νh(huán)境保護(hù)的日益重視這些大環(huán)境下,A醫(yī)藥企業(yè)面臨著前所未有的市場(chǎng)壓力。企業(yè)深知要突出重圍,只有不斷地依靠提高內(nèi)部管理水平、吸取先進(jìn)藥企成功的管理理念,不斷通過(guò)技術(shù)進(jìn)步和強(qiáng)化管理來(lái)提高生產(chǎn)運(yùn)行的效率、降低產(chǎn)品的成本、提升產(chǎn)品的品質(zhì)、加快市場(chǎng)響應(yīng)的速度。而精益生產(chǎn)正是經(jīng)過(guò)前人不斷驗(yàn)證過(guò)的一種成功的生產(chǎn)經(jīng)營(yíng)模式,A醫(yī)藥企業(yè)根據(jù)企業(yè)自身發(fā)展的需求,尋求精益生產(chǎn)方式的革新之路,希望通過(guò)在企業(yè)推行精益生產(chǎn),快速提升企業(yè)目前的管理質(zhì)態(tài),通過(guò)持續(xù)改進(jìn)提高公司的市場(chǎng)競(jìng)爭(zhēng)力,從而擺脫目前的困境并尋求新的突破和生存發(fā)展的空間。 本文以筆者所在A醫(yī)藥企業(yè)為背景,在全面分析企業(yè)當(dāng)前生產(chǎn)運(yùn)營(yíng)現(xiàn)狀的基礎(chǔ)上,借鑒精益生產(chǎn)的理論和方法,從企業(yè)發(fā)展的視角出發(fā),結(jié)合藥企流程制造的特點(diǎn),探索將相關(guān)精益生產(chǎn)理論和方法靈活應(yīng)用于背景制藥企業(yè),完成了制藥企業(yè)精益改善的實(shí)施方案設(shè)計(jì)并以項(xiàng)目管理的思路系統(tǒng)實(shí)施。實(shí)施效果表明,通過(guò)精益生產(chǎn)的系統(tǒng)推進(jìn),企業(yè)在成本、質(zhì)量、效率、設(shè)備保障等方面均取得了顯著的改善,同時(shí)員工的行為和意識(shí)也發(fā)生了顯著的變化,為構(gòu)建現(xiàn)代企業(yè)文化奠定了基礎(chǔ)。
[Abstract]:With the development of economic globalization, the competition of Chinese medicine industry is becoming more and more white. By virtue of their strong economic strength and advanced product technology, foreign large pharmaceutical enterprises continue to occupy the high-end pharmaceutical market in China. At the same time, the domestic private pharmaceutical enterprises, relying on efficient and flexible operation model and management mechanism, constantly use the price war to seize the low end of the drug market. In the face of such fierce competition, quality and price have become the key factor of success or failure of enterprise market. The enterprises represented by Toyota Company reduce the cost, improve the quality, respond to the market quickly and flexibly through lean production, and obtain great success, which brings new hope for the domestic pharmaceutical enterprises which are in the weak position of competition. In the current domestic pharmaceutical market, the variety of generic drugs is constantly increasing, the new medical reform policy continues to exert pressure on drug prices, the requirements of the State Drug Regulatory Agency for the examination and approval of drug quality are greatly increased, and as the RMB continues to appreciate, With the rising labor cost and the increasing attention to environmental protection in the Taihu Basin, A pharmaceutical enterprise is facing unprecedented market pressure. Enterprises are well aware that they must constantly rely on improving the level of internal management, absorbing the successful management concepts of advanced pharmaceutical enterprises, constantly improving the efficiency of production and operation through technological progress and strengthening management, and reducing the cost of products. Improve product quality and speed up market response. Lean production is a successful mode of production and management, which has been continuously verified by predecessors. According to the needs of the enterprise's own development, A pharmaceutical enterprise seeks the way of innovation of lean production mode, hoping to carry out lean production in the enterprise. We can quickly improve the management quality of the enterprise, improve the market competitiveness of the company through continuous improvement, so as to get rid of the current predicament and seek for new breakthrough and space for survival and development. In this paper, based on the comprehensive analysis of the current production and operation status of A pharmaceutical enterprise, the author draws lessons from the theory and method of lean production, from the perspective of enterprise development, combining the characteristics of pharmaceutical enterprise process manufacturing. This paper explores the flexible application of relevant lean production theories and methods to pharmaceutical enterprises, completes the implementation scheme design of lean improvement in pharmaceutical enterprises and implements it systematically with the idea of project management. The implementation results show that, through the systematic promotion of lean production, enterprises have made significant improvements in cost, quality, efficiency, equipment support, etc. At the same time, the behavior and consciousness of employees have also changed significantly. For the construction of modern corporate culture laid the foundation.
【學(xué)位授予單位】：南京理工大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2013
【分類號(hào)】：F273;F426.72

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 方琳;黃健求;殷素峰;;5S管理在校-系分級(jí)教學(xué)管理中的運(yùn)用[J];甘肅科技;2010年03期

2 王興;;淺析“減少浪費(fèi)”在精益生產(chǎn)中的應(yīng)用[J];東方企業(yè)文化;2012年15期

3 韓會(huì)娟;;淺談QC小組活動(dòng)的作用及推進(jìn)[J];科技情報(bào)開發(fā)與經(jīng)濟(jì);2008年02期

4 王美會(huì);;基于約束理論的企業(yè)流程管理[J];科技信息;2012年17期

5 趙志宏;;制藥企業(yè)全員生產(chǎn)維修(TPM)的實(shí)施及意義[J];機(jī)電信息;2012年35期

6 程新建;;精益管理在我國(guó)企業(yè)中的應(yīng)用對(duì)策分析[J];齊魯石油化工;2011年02期

7 梅清晨;;TPM管理體系推進(jìn)方法研究[J];中國(guó)設(shè)備工程;2011年01期

8 王學(xué)民,曹順民,劉娟;六西格瑪項(xiàng)目與QC小組活動(dòng)的一致性[J];石油工業(yè)技術(shù)監(jiān)督;2005年02期

9 黃敏;干榮富;;新醫(yī)改政策對(duì)醫(yī)藥行業(yè)影響分析[J];中國(guó)醫(yī)藥工業(yè)雜志;2011年05期

10 吳忷峰;;新醫(yī)改對(duì)醫(yī)藥企業(yè)的挑戰(zhàn)與企業(yè)的戰(zhàn)略思路[J];中國(guó)執(zhí)業(yè)藥師;2009年08期

，

本文編號(hào)：2345402